Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients
NCT ID: NCT02499185
Last Updated: 2018-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
100 participants
INTERVENTIONAL
2015-04-01
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Kidney Injury - Biomarkers in Major Abdominal Surgery
NCT04582747
TIMP-2 and IGFBP7 for the Prediction of the Cardiac Surgery Associated Acute Kidney Injury
NCT02054546
(TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury (AKI) in Aortic Surgery
NCT03469765
Urine Biomarkers to Predict Acute Kidney Injury After Pediatric Cardiac Surgery
NCT05637424
AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)
NCT00780845
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nephro Check Test
We take urine samples and analyse the level of \[TIMP-2\]●\[IGFBP-7\] using the NephroCheck Test to diagnose AKI
Nephro Check Test
Urine sample
serum creatinine measurement
Blood sample
serum creatinine measurement
This is the "Golden standard" to diagnose AKI
Nephro Check Test
Urine sample
serum creatinine measurement
Blood sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nephro Check Test
Urine sample
serum creatinine measurement
Blood sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High risk patients: General Surgery AKI Risk Index Class III, IV or V
* Major abdominal surgery
Exclusion Criteria
* History of kidney transplant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitair Ziekenhuis Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Veerle Van Mossevelde
Data Nurse
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lien Torisaen, MD
Role: PRINCIPAL_INVESTIGATOR
Universitair Ziekenhuis Brussel
Jan Poelaert, Prof.Dr.
Role: STUDY_CHAIR
Universitair Ziekenhuis Brussel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis Brussel
Jette, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NOVELBIO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.